Efficacy and Safety of ALT-801 in the Treatment of Obesity
NCT05295875
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
391
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity/Overweight
Interventions
DRUG:
ALT-801
OTHER:
Placebo
Sponsor
Altimmune, Inc.